Cargando…
Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
Urinary albumin excretion is an early sign of diabetic kidney disease, affecting every third individual with diabetes. Despite substantial estimated heritability, only variants in the GLRA3 gene have been genome-wide significantly associated (p-value < 5 × 10(−8)) with diabetic albuminuria, in Fi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098108/ https://www.ncbi.nlm.nih.gov/pubmed/30120300 http://dx.doi.org/10.1038/s41598-018-29211-1 |
_version_ | 1783348406122446848 |
---|---|
author | Sandholm, Niina Haukka, Jani K Toppila, Iiro Valo, Erkka Harjutsalo, Valma Forsblom, Carol Groop, Per-Henrik |
author_facet | Sandholm, Niina Haukka, Jani K Toppila, Iiro Valo, Erkka Harjutsalo, Valma Forsblom, Carol Groop, Per-Henrik |
author_sort | Sandholm, Niina |
collection | PubMed |
description | Urinary albumin excretion is an early sign of diabetic kidney disease, affecting every third individual with diabetes. Despite substantial estimated heritability, only variants in the GLRA3 gene have been genome-wide significantly associated (p-value < 5 × 10(−8)) with diabetic albuminuria, in Finnish individuals with type 1 diabetes; However, replication attempt in non-Finnish Europeans with type 1 diabetes showed nominally significant association in the opposite direction, suggesting a population-specific effect, but simultaneously leaving the finding controversial. In this study, the association between the common rs10011025 variant in the GLRA3 locus, and albuminuria, was confirmed in 1259 independent Finnish individuals with type 1 diabetes (p = 0.0013), and meta-analysis of all Finnish individuals yielded a genome-wide significant association. The association was particularly pronounced in subjects not reaching the treatment target for blood glucose levels (HbA(1c) > 7%; N = 2560, p = 1.7 × 10(−9)). Even though further studies are needed to pinpoint the causal variants, dissecting the association at the GLRA3 locus may uncover novel molecular mechanisms for diabetic albuminuria irrespective of population background. |
format | Online Article Text |
id | pubmed-6098108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60981082018-08-23 Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes Sandholm, Niina Haukka, Jani K Toppila, Iiro Valo, Erkka Harjutsalo, Valma Forsblom, Carol Groop, Per-Henrik Sci Rep Article Urinary albumin excretion is an early sign of diabetic kidney disease, affecting every third individual with diabetes. Despite substantial estimated heritability, only variants in the GLRA3 gene have been genome-wide significantly associated (p-value < 5 × 10(−8)) with diabetic albuminuria, in Finnish individuals with type 1 diabetes; However, replication attempt in non-Finnish Europeans with type 1 diabetes showed nominally significant association in the opposite direction, suggesting a population-specific effect, but simultaneously leaving the finding controversial. In this study, the association between the common rs10011025 variant in the GLRA3 locus, and albuminuria, was confirmed in 1259 independent Finnish individuals with type 1 diabetes (p = 0.0013), and meta-analysis of all Finnish individuals yielded a genome-wide significant association. The association was particularly pronounced in subjects not reaching the treatment target for blood glucose levels (HbA(1c) > 7%; N = 2560, p = 1.7 × 10(−9)). Even though further studies are needed to pinpoint the causal variants, dissecting the association at the GLRA3 locus may uncover novel molecular mechanisms for diabetic albuminuria irrespective of population background. Nature Publishing Group UK 2018-08-17 /pmc/articles/PMC6098108/ /pubmed/30120300 http://dx.doi.org/10.1038/s41598-018-29211-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Sandholm, Niina Haukka, Jani K Toppila, Iiro Valo, Erkka Harjutsalo, Valma Forsblom, Carol Groop, Per-Henrik Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
title | Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
title_full | Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
title_fullStr | Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
title_full_unstemmed | Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
title_short | Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
title_sort | confirmation of glra3 as a susceptibility locus for albuminuria in finnish patients with type 1 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098108/ https://www.ncbi.nlm.nih.gov/pubmed/30120300 http://dx.doi.org/10.1038/s41598-018-29211-1 |
work_keys_str_mv | AT sandholmniina confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes AT haukkajanik confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes AT toppilaiiro confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes AT valoerkka confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes AT harjutsalovalma confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes AT forsblomcarol confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes AT groopperhenrik confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes |